The invention refers to the use of an engineered 'Clustered Regularly Interspersed Short Palindromic Repeat (CRISPR)-CRISPR associated (Cas)’ (CRISPR-Cas) technology targeting a sequence mutated at one or more loci in the genome of a given eukaryotic cell
The present invention represents an in vitro implementable method and related kit for assessing the response to immune tolerance restoration therapy by evaluating the expression of specific microRNAs (miRNAs) as biomarkers of residual beta-cell function.
The present invention consists of an electromechanical stimulation system, and related wearable device, generating and transmitting mechanical vibrations to the bone processes near a user's ear.
The invention consists of alternative compounds to nitisinone, for the treatment of both AKU and HT1.
This invention makes it possible to study in depth the phenomena involved in the ultrasonic stimulation of living materials and cells, thus paving the way for the optimisation of these stimulation processes in numerous areas
The invention relates to a device for detecting the position and movement of a human limb through a plurality of sensors and a unit that manages the data and the respective flow.
The invention relates to a system for the localization and magnetic locomotion of an endoscopic capsule within a gastrointestinal tract
The present invention relates to an artificial sphincter for implantation in a urethral canal, in particular for treating patients suffering from urinary incontinence.
The invention relates a system made of a mechanical structure and a microfiltration system at the end of the VAD, allowing the separation of erithrocytes from the other blood components.
The invention relates to an artificial bladder that can be implanted in a patient's body for the collection and discharge of urinary biological fluids
